Top

BY Judy Overton and Jeanie Woodruff

Researchers at MD Anderson believe the diabetes drug metformin, the most widely used prescription drug in the world, can protect against chemotherapy-induced peripheral neuropathy (CIPN) and sensory deficits.

The results of the study, led by Cobi Heijnen, Ph.D., professor in Symptom Research, were reported in the June 23 edition of PLOS One.

“We were interested in finding an agent that could combat the pain and numbness...

metformin protects against chemotherapy-induced peripheral neuropathy (CIPN)